MLL
Moody Lynn & Lieberson’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-22,428
| Closed | -$3.09M | – | 244 |
|
|
2024
Q1 | $3.09M | Buy |
+22,428
| New | +$3.09M | 0.21% | 77 |
|
|
2023
Q1 | – | Sell |
-34,645
| Closed | -$4.14M | – | 228 |
|
|
2022
Q4 | $4.14M | Sell |
34,645
-35
| -0.1% | -$4.18K | 0.38% | 60 |
|
|
2022
Q3 | $3.68M | Sell |
34,680
-5
| -0% | -$531 | 0.36% | 61 |
|
|
2022
Q2 | $3.38M | Buy |
+34,685
| New | +$3.38M | 0.3% | 66 |
|
|
2020
Q4 | – | Sell |
-10,351
| Closed | -$995K | – | 214 |
|
|
2020
Q3 | $995K | Buy |
+10,351
| New | +$995K | 0.1% | 101 |
|
|
2018
Q4 | – | Sell |
-4,243
| Closed | -$522K | – | 204 |
|
|
2018
Q3 | $522K | Buy |
+4,243
| New | +$522K | 0.06% | 151 |
|